Health Care & Life Sciences » Pharmaceuticals | Protect Pharmaceutical Corp.

Protect Pharmaceutical Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
2017
SG&A Expense
554.30
23.90
30.80
30.00
41.70
115.40
EBIT
554.30
23.90
30.90
30.00
41.70
115.40
Unusual Expense
-
-
489.00
605.40
-
-
Pretax Income
554.30
23.90
458.10
635.50
41.70
122.60
Consolidated Net Income
554.30
23.90
458.10
635.50
41.70
122.60
Net Income
554.30
23.90
458.10
635.50
41.70
122.60
Net Income After Extraordinaries
554.30
23.90
458.10
635.50
41.70
122.60
Net Income Available to Common
554.30
23.90
458.10
635.50
41.70
122.60
EPS (Basic)
10.00
0.54
8.48
1.44
0.04
0.11
Basic Shares Outstanding
44.60
44.60
54.00
442.20
1,111.50
1,111.50
EPS (Diluted)
12.44
0.54
8.48
1.44
0.04
0.11
Diluted Shares Outstanding
44.60
44.60
54.00
442.20
1,111.50
1,111.50
EBITDA
554.30
23.90
30.90
30.00
41.70
115.40

About Protect Pharmaceutical

View Profile
Address
4876, Cecile Avenue
Las Vegas Nevada 89115
United States
Employees -
Website -
Updated 07/08/2019
Protect Pharmaceutical Corp. is a drug delivery and new product development company. The company was founded on August 5, 1987 and is headquartered in Salt Lake City, UT. .